Retrotransposable Element Expression in Neural Stem Cell Senescence and Aging
Retrotransposable Element Expression in Neural Stem Cell Senescence and Aging
批准号:
10210271
负责人:
Jill Kreiling
金额:
$19.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-06-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAntibodiesArchitectureAttenuatedBiological AssayCell AgingCell Cycle ArrestCell Cycle RegulationChIP-seqChromatinChromatin StructureDNADNA DamageDataDementiaDevelopmentDiploidyDiscriminationEconomic BurdenElementsEnzymesEventExposure toFibroblastsFunctional disorderGene ExpressionGenomeGenomic InstabilityGenomicsHeterochromatinHistonesHumanImmunofluorescence ImmunologicImpaired cognitionIn VitroInsertional MutagenesisKnowledgeL1 ElementsLaboratoriesLamivudineLeadLiverMethodsMusMuscleNatural regenerationNerve DegenerationNeuronsNuclearPathway interactionsPhenotypePlayProductivityRepetitive SequenceReporterRepressionReverse Transcriptase InhibitorsRisk FactorsRoleTestingTherapeutic InterventionTimeTissuesTransposaseTreatment CostVariantWorkagedcell agecell typechromatin immunoprecipitationcostcost estimatedesigndesign and constructioneffective therapyexperimental studyfunctional declinegene repressiongenome-widegenotoxicityhealthspanin vivoinsightmammalian genomenerve stem cellneurogenesisneuromechanismnucleoside analogolfactory bulbresponsesenescencestem cell agingstem cell functiontelomeretranscriptometranscriptome sequencingwhole genome
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Neurodegenerative conditions and dementias, including Alzheimer's disease, create a significant economic
burden and are responsible for considerable human suffering. Aging is the primary risk factor for development
of these conditions. The decline in neural stem cell (NSC) function that occurs with age is a major factor
contributing to the development of these conditions. However, the mechanisms resulting in NSC functional
decline are poorly understood. Recent work from our laboratory and others reveals that chromatin undergoes
global remodeling with age, with an opening of heterochromatic regions and a relative closing of euchromatic
regions. The highly heterochromatic regions contain large numbers of retrotransposable elements (RTEs). We
have previously shown that RTE expression also increases with age and culminates in active transposition
events. Somatic transposition can lead to insertional mutagenesis and genome rearrangements creating genome
instability and triggering cellular senescence. This leads us to our hypothesis: Age-associated changes in
chromatin structure lead to de-repression of RTEs, resulting in DNA damage and genome instability,
ultimately triggering cellular senescence and a decline in NSC function. To test this hypothesis we will
perform a set of experiments designed to determine the role of increased RTE expression with age in loss of
NSC function. In Specific Aim 1 we will begin by investigating the chromatin architecture in senescent and aged
NSCs, and determine the effects on the transcriptome, in particular on the expression of RTEs. To obtain
reinforcing and complementary whole genome data, we will use high-throughput Illumina sequencing in
conjunction with three methods to define changes in chromatin structure and function: assay for transposase
accessible chromatin (ATAC-seq), chromatin immunoprecipitation using antibodies against repressive and
activating chromatin histone marks (ChIP-seq), and RNA-seq to define the transcriptome, including RTE
expression. Specific Aim 2 will investigate the relationship between RTE expression and DNA damage
accumulation in NSC functional decline. We will determine the dynamics of DNA damage accumulation and
senescence in NSCs over time. The effects of RTE deregulation on NSC function and senescence will be
determined using a reporter construct designed to over express the long interspersed nuclear element L1.
Finally, we will determine the role of RTE expression in NSC functional decline in vivo in Specific Aim 3. The
effect of RTE de-repression on the ability of NSCs to regenerate neurons in the olfactory bulb will be investigated
through olfactory discrimination tests in young and aged mice exposed to the reverse transcriptase inhibitor 3TC,
which represses RTE transposition. To determine if RTE repression extends NSC healthspan, the neurogenic
capabilities of NSCs will be investigated in 3TC treated mice. Taken together the results of the experiments
outlined in this proposal will give us new insight into the mechanisms that result in NSC functional decline with
age and may ultimately lead to therapeutic interventions that can extend human healthspan.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders
-
批准号:10447414
-
项目类别:
-
资助金额:$82.21万
-
财政年份:2022
-
负责人:Jill Kreiling
-
依托单位:
Salivary Extracellular Vesicles as Biomarkers for Alzheimer's Disease and Related Disorders
-
批准号:10620750
-
项目类别:
-
资助金额:$79.31万
-
财政年份:2022
-
负责人:Jill Kreiling
-
依托单位:
Regulation of Age-Associated Heterochromatin Formation
-
批准号:8334065
-
项目类别:
-
资助金额:$11.66万
-
财政年份:2011
-
负责人:Jill Kreiling
-
依托单位:
Regulation of Age-Associated Heterochromatin Formation
-
批准号:8721818
-
项目类别:
-
资助金额:$11.63万
-
财政年份:2011
-
负责人:Jill Kreiling
-
依托单位:
Regulation of Age-Associated Heterochromatin Formation
-
批准号:8242212
-
项目类别:
-
资助金额:$11.68万
-
财政年份:2011
-
负责人:Jill Kreiling
-
依托单位:
Regulation of Age-Associated Heterochromatin Formation
-
批准号:8520146
-
项目类别:
-
资助金额:$11.65万
-
财政年份:2011
-
负责人:Jill Kreiling
-
依托单位:
Regulation of Age-Associated Heterochromatin Formation
-
批准号:8871504
-
项目类别:
-
资助金额:$11.62万
-
财政年份:2011
-
负责人:Jill Kreiling
-
依托单位:
THE EFFECTS OF EARLY EMBRYONIC EXPOSURE TO PCBS ON THE DEVELOPING NERVOUS SYSTEM
-
批准号:7725164
-
项目类别:
-
资助金额:$3.11万
-
财政年份:2008
-
负责人:Jill Kreiling
-
依托单位:
Retrotransposable Element Expression in Neural Stem Cell Senescence and Aging
-
批准号:9356959
-
项目类别:
-
资助金额:$24.61万
-
财政年份:--
-
负责人:Jill Kreiling
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: